Stock Trend Analysis Report
Prepared for you on Sunday, May 9, 2021.
Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)
Sidelines Mode (+55) - CNCR is moving in a sideways pattern and is unable to gain momentum in either direction. Beware of choppy movement and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid CNCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for CNCR
The long-term trend has been DOWN since Mar 3rd, 2021 at 30.72
The intermediate-term trend has been UP since Apr 22nd, 2021 at 30.45
The short-term trend has been DOWN since Apr 28th, 2021 at 30.30
Smart Scan Analysis for CNCR
Based on our trend formula, CNCR is rated as a +55 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||32.32||Year High Date||2018-03-13|
|Year Low||19.1252||Year Low Date||2018-10-29|
|52wk High||35.818||52wk High Date||2021-02-08|
|52wk Low||23.5||52wk Low Date||2020-05-07|
|Average Volume||7,835||Shares Outstanding||100|